Marie Thibault
Stock Analyst at BTIG
(0.03)
# 4,413
Out of 4,423 analysts
710
Total ratings
33.4%
Success rate
-14.3%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Maintained: Buy | $80 | $72.47 | +10.39% | 54 | Jun 15, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $100 | $87.36 | +14.47% | 41 | Jun 15, 2026 | |
| HAE Haemonetics | Rated: Buy | $84 | $74.17 | +13.25% | 12 | Jun 15, 2026 | |
| PODD Insulet | Maintained: Buy | $235 | $145.76 | +61.22% | 50 | Jun 15, 2026 | |
| SENS Senseonics Holdings | Maintained: Hold | n/a | $6.74 | - | 38 | Jun 15, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $185 | $104.65 | +76.78% | 59 | Jun 15, 2026 | |
| HYPR Hyperfine | Maintained: Buy | $2 | $1.60 | +25.00% | 3 | Jun 15, 2026 | |
| EMBC Embecta | Maintained: Hold | n/a | $3.11 | - | 28 | Jun 15, 2026 | |
| KMTS Kestra Medical Technologies | Maintained: Buy | $30 | $19.93 | +50.53% | 8 | Jun 15, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $25 | $14.77 | +69.26% | 3 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $65 | $45.29 | +43.52% | 75 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $28 | $18.03 | +55.30% | 11 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.3479 | - | 38 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $45 | $28.80 | +56.25% | 50 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $131 | $88.41 | +48.17% | 52 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.36 | - | 15 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $11.69 | +96.75% | 29 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.99 | - | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.05 | +197.03% | 18 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $84.81 | n/a | 55 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $298.01 | n/a | 1 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $317.20 | n/a | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 37 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 | $79.34 | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.23 | n/a | 23 | Dec 16, 2022 |
DexCom
Jun 15, 2026
Maintained: Buy
Price Target: $80
Current: $72.47
Upside: +10.39%
Edwards Lifesciences
Jun 15, 2026
Maintained: Buy
Price Target: $100
Current: $87.36
Upside: +14.47%
Haemonetics
Jun 15, 2026
Rated: Buy
Price Target: $84
Current: $74.17
Upside: +13.25%
Insulet
Jun 15, 2026
Maintained: Buy
Price Target: $235
Current: $145.76
Upside: +61.22%
Senseonics Holdings
Jun 15, 2026
Maintained: Hold
Price Target: n/a
Current: $6.74
Upside: -
iRhythm Holdings
Jun 15, 2026
Maintained: Buy
Price Target: $185
Current: $104.65
Upside: +76.78%
Hyperfine
Jun 15, 2026
Maintained: Buy
Price Target: $2
Current: $1.60
Upside: +25.00%
Embecta
Jun 15, 2026
Maintained: Hold
Price Target: n/a
Current: $3.11
Upside: -
Kestra Medical Technologies
Jun 15, 2026
Maintained: Buy
Price Target: $30
Current: $19.93
Upside: +50.53%
MiniMed Group
Jun 15, 2026
Maintained: Buy
Price Target: $25
Current: $14.77
Upside: +69.26%
Jun 3, 2026
Reiterated: Buy
Price Target: $80 → $65
Current: $45.29
Upside: +43.52%
May 12, 2026
Reiterated: Buy
Price Target: $30 → $28
Current: $18.03
Upside: +55.30%
May 7, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3479
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $54 → $45
Current: $28.80
Upside: +56.25%
Apr 17, 2026
Maintained: Buy
Price Target: $131
Current: $88.41
Upside: +48.17%
Mar 26, 2026
Maintained: Hold
Price Target: n/a
Current: $0.36
Upside: -
Feb 18, 2026
Maintained: Buy
Price Target: $23
Current: $11.69
Upside: +96.75%
Feb 18, 2026
Maintained: Hold
Price Target: n/a
Current: $3.99
Upside: -
Feb 18, 2026
Maintained: Buy
Price Target: $15
Current: $5.05
Upside: +197.03%
Apr 10, 2025
Reiterated: Buy
Price Target: $62
Current: $84.81
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $150
Current: $298.01
Upside: n/a
Jul 26, 2023
Rated: Buy
Price Target: n/a
Current: $317.20
Upside: n/a
Jul 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Feb 21, 2023
Rated: Hold
Price Target: $89
Current: $79.34
Upside: n/a
Dec 16, 2022
Rated: Hold
Price Target: n/a
Current: $1.23
Upside: n/a